type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 06/12/2026 | 06/18/2026 | 0.12542000 |
| Dividends | 12/16/2025 | 12/19/2025 | 0.15500000 |
| Dividends | 06/16/2025 | 06/20/2025 | 0.15300000 |
| Dividends | 12/17/2024 | 12/20/2024 | 0.11100000 |
| Dividends | 06/11/2024 | 06/17/2024 | 0.11144000 |
| Dividends | 12/21/2023 | 12/27/2023 | 0.16920000 |
| Dividends | 06/08/2023 | 06/13/2023 | 0.07077000 |
| Dividends | 06/10/2022 | 06/15/2022 | 0.13590000 |
| Dividends | 12/14/2021 | 12/17/2021 | 0.25636000 |
| Dividends | 06/11/2021 | 06/16/2021 | 0.05215000 |
| Dividends | 12/15/2020 | 12/18/2020 | 0.03621000 |
| Dividends | 06/16/2020 | 06/19/2020 | 0.08367000 |
| Dividends | 12/17/2019 | 12/20/2019 | 0.24000000 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| MRNA | Stock | Healthcare | US$ 58.11 B | 9,59% | |
| TWST | Stock | Healthcare | US$ 8.21 B | 5,63% | |
| RVMD | Stock | Healthcare | US$ 45.01 B | 4,15% | |
Bayer AG NA
|
BAYN | Stock | Healthcare | US$ 47.99 B | 4,00% |
| GMAB | Stock | Healthcare | US$ 133.07 B | 3,99% | |
| REGN | Stock | Healthcare | US$ 86.84 B | 3,82% | |
| MRK | Stock | Healthcare | US$ 370.89 B | 3,66% | |
| VRTX | Stock | Healthcare | US$ 141.42 B | 3,61% | |
| INCY | Stock | Healthcare | US$ 25.69 B | 3,60% | |
|
Takeda Pharmaceutical Co. Ltd.
|
4502 | - | Healthcare | - | 3,50% |
| BNTX | Stock | Healthcare | US$ 26.06 B | 3,41% | |
| EXEL | Stock | Healthcare | US$ 14.62 B | 3,18% | |
Ipsen SA
|
IPN | Stock | Healthcare | US$ 13.60 B | 3,14% |
| IDYA | Stock | Healthcare | US$ 3.85 B | 3,07% | |
| ROP | Stock | Healthcare | US$ 283.89 B | 3,06% | |
| IOVA | Stock | Healthcare | US$ 3.94 B | 2,97% | |
| SAN | Stock | Healthcare | US$ 91.36 B | 2,92% | |
| GSK | Stock | Healthcare | US$ 101.88 B | 2,88% | |
|
Caris Life Sciences, Inc. Common Stock
|
CAI | Stock | Healthcare | US$ 7.16 B | 2,81% |
| IBRX | Stock | Healthcare | US$ 8.68 B | 2,74% | |
| ABCL | Stock | Healthcare | US$ 3.75 B | 2,45% | |
Arcus Biosciences Inc
|
RCUS | Stock | Healthcare | US$ 3.73 B | 2,30% |
|
Ono Pharmaceutical Ltd
|
4528 | - | Healthcare | - | 1,61% |
| NUVB | Stock | Healthcare | US$ 2.38 B | 1,52% | |
| CRSP | Stock | Healthcare | US$ 5.46 B | 1,51% | |
| NVAX | Stock | Healthcare | US$ 1.69 B | 1,47% | |
| VIR | Stock | Healthcare | US$ 1.93 B | 1,43% | |
| KURA | Stock | Healthcare | US$ 1.17 B | 1,02% | |
Janux Therapeutics Inc
|
JANX | Stock | Healthcare | US$ 1.21 B | 1,00% |
| PSNL | Stock | Healthcare | US$ 1.84 B | 0,98% | |
| CRVS | Stock | Healthcare | US$ 1.23 B | 0,83% | |
| RIGL | Stock | Healthcare | US$ 909.15 M | 0,79% | |
|
SUNSHINE LAKE PHARMA CO LTD
|
6887 | Stock | Healthcare | US$ 21.53 B | 0,72% |
|
GenFleet Therapeutics
|
2595 | - | Healthcare | - | 0,64% |
| CTMX | Stock | Healthcare | US$ 801.87 M | 0,59% | |
| VSTM | Stock | Healthcare | US$ 742.62 M | 0,58% | |
| XNCR | Stock | Healthcare | US$ 1.98 B | 0,58% | |
Alvotech
|
ALVO | Stock | Healthcare | US$ 1.88 B | 0,55% |
| DSGN | Stock | Healthcare | US$ 940.60 M | 0,53% | |
|
Shanghai Henlius Biotech Inc
|
2696 | Stock | Healthcare | US$ 38.22 B | 0,50% |
| NTLA | Stock | Healthcare | US$ 1.78 B | 0,50% | |
Valneva SE
|
VLA | Stock | Healthcare | US$ 555.67 M | 0,48% |
| OCGN | Stock | Healthcare | US$ 461.19 M | 0,41% | |
| PACB | Stock | Healthcare | US$ 419.62 M | 0,34% | |
| DNA | Stock | Healthcare | US$ 468.01 M | 0,30% | |
|
AbClon Inc
|
174900 | Stock | Healthcare | US$ 430.39 B | 0,25% |
| PRME | Stock | Healthcare | US$ 671.09 M | 0,10% |
Average Investor10 user rating
4.0
(4 people)
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (United States) is an exchange-traded fund (ETF), with assets under management totaling $263.57 million.
Over the past 12 months, iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund recorded a return of 75.40%, with its price trading between $22.46 and $41.48 during the same period.
The ETF is traded under the ticker IDNA.
The current price of IDNA is $39.83. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
IDNA is currently trading at $39.83, with a market capitalization of approximately $263.566.369,00. Over the past year, the ETF has delivered a 75.40% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in IDNA through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol IDNA, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, IDNA has returned -0.62%, and 75.40% over the past year.
If you were to purchase 100 shares of IDNA at the current price of $39.83, your total investment would be $3,983.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
